A couple things I pick up on the 10-Q. First The remaining milestones to Montigen group. A total $12M remains. They will have the next milestone when MP-529 enters clinics. Then upon the first NDA of a montigens pipeline, a $7M milestone to the Montigen group. All these payments are with SUPG stock.
On the other side of the equation. Outstating milestones that SUPG will receive. MGI still owes $12.5M and I believe ADOPT and AML probably will trigger the majority of this milestone. JNJ has remaining $23.75M and since they will probably take the whole package for approval in EU, I would think that the majority of this milestone would be earned by SUPG. Our share price will rebound soon. 2008 is right around the corner and ADOPT news will be released no later than ASH conference.
American Society of Hematology is DEC. 6-9. I still think we get a preliminary update by MGI. 12-24 cycles is big news. The July IMS figures will be released around approx. Aug. 29. So we could see a nice term here to acquire more shares.